Sharon Ward-Fore, MS, MT(ASCP), CIC, says that non-healthcare companies need a lot of help following infection prevention and control guidelines. They may call on infection preventionists for that help.
The efforts of many private industries and government institutions to create infection prevention and control programs are downright cringe-worthy, says Sharon Ward-Fore, MS, MT(ASCP), CIC, an infection prevention consultant, and member of Infection Control Today®’s Editorial Advisory Board. For instance, Ward-Fore witnessed one large retailer issue face shields to its cashiers without also issuing masks (a violation of OSHA standards). Other employees at the same store wore cloth masks below their noses. She hopes that infection preventionists will be called upon to offer their expertise. It’s also possible that IPs will be hired in non-healthcare settings thanks to the confusion caused by coronavirus disease 2019 (COVID-19).
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
Our Understanding of Immune Issues Is Evolving: Here Are 5 Reasons Why
October 25th 2024The past 5 years in medicine have seen significant advances in RNA vaccines, understanding immune dysregulation, and improved interspecialty communication, promising better disease eradication and tailored treatments.